Cartesian Therapeutics, Inc. (RNAC) vs Exagen Inc. (XGN)
A side-by-side comparison of Cartesian Therapeutics, Inc. and Exagen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RNAC
Cartesian Therapeutics, Inc.
$6.97HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
XGN
Exagen Inc.
$8.40HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — RNAC vs XGN
growth of $100 · dividends reinvested · last 7yRNAC -86.9% (-25.2%/yr)XGN -54.5% (-10.6%/yr)XGN compounded faster over this window
RNAC XGN
RNAC vs XGN: by the numbers
- •RNAC is the larger company ($205M vs $203M market cap).
- •Both run net losses; XGN's is the smaller (-26.61% vs -10422.48% net margin).
- •XGN grew revenue faster over the past five years (8.73% vs -50.01% CAGR).
Metrics side by side
Valuation
| Metric | RNAC | XGN |
|---|---|---|
| P/S ratio | 138.63 | 2.85 |
| P/B ratio | N/A | 16.61 |
Profitability
| Metric | RNAC | XGN |
|---|---|---|
| Gross margin | 100.00% | 58.64% |
| Operating margin | -3099.93% | -18.58% |
| Net margin | -10422.48% | -26.61% |
| ROE | N/A | -154.90% |
| ROIC | -33.10% | -33.88% |
Growth (annualized)
| Metric | RNAC | XGN |
|---|---|---|
| Revenue CAGR (5Y) | -50.01% | 8.73% |
| Total return CAGR (5Y) | -44.03% | -8.40% |
Frequently asked
- Which has grown faster, RNAC or XGN?
- Over the past five years, XGN grew revenue faster — RNAC at a -50.01% CAGR versus XGN at 8.73%.
- How have RNAC and XGN total returns compared?
- Over the past 5 years, RNAC delivered -44.03% and XGN delivered -8.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.